OtherCardiovascular
Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin
Dexter L. Lee, Brian R. Wamhoff, Laxmansa C. Katwa, Hannumanth K. Reddy, Joseph L. Dixon and Michael S. Sturek
Journal of Pharmacology and Experimental Therapeutics March 27, 2003, DOI: https://doi.org/10.1124/jpet.103.049577
Dexter L. Lee
Brian R. Wamhoff
Laxmansa C. Katwa
Hannumanth K. Reddy
Joseph L. Dixon

This is a PDF-only article. The first page of the PDF of this article appears below.

In this issue
OtherCardiovascular
Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin
Dexter L. Lee, Brian R. Wamhoff, Laxmansa C. Katwa, Hannumanth K. Reddy, Joseph L. Dixon and Michael S. Sturek
Journal of Pharmacology and Experimental Therapeutics March 27, 2003, DOI: https://doi.org/10.1124/jpet.103.049577
OtherCardiovascular
Increased Endothelin-Induced Ca2+ Signaling, Tyrosine Phosphorylation, and Coronary Artery Disease in Diabetic Dyslipidemic Swine Are Prevented by Atorvastatin
Dexter L. Lee, Brian R. Wamhoff, Laxmansa C. Katwa, Hannumanth K. Reddy, Joseph L. Dixon and Michael S. Sturek
Journal of Pharmacology and Experimental Therapeutics March 27, 2003, DOI: https://doi.org/10.1124/jpet.103.049577